FRANKFURT, Germany, Nov. 15, 2025 — Vnzymes, the new European subsidiary and brand of VTR Biotech Group, today announced the opening of its Frankfurt office, marking a key step in the company’s global growth. The move highlights Vnzymes’ dedication to fostering innovation in animal nutrition, industrial enzymes, and sustainable agriculture in Europe and beyond.
Built upon VTR Biotech’s global resources and scientific expertise, Vnzymes offers biosolutions that advance sustainability, efficiency, and responsible practices. The Frankfurt office will be the center for the company’s European activities, supporting research and development, technical support, and localized market growth to meet regional demands.
Cindy Chen, CEO of Vnzymes, stated that for over 30 years, VTR Biotech has pursued its mission of ‘Bioscience Impact Tomorrow’, furthering the research, development, and application of enzyme preparations, biosynthetic products, and plant extracts. She added that the launch of Vnzymes in Europe establishes a platform that utilizes their global knowledge and addresses specific local market needs in animal nutrition and health, providing significant value to their partners, clients, and communities.
Originating in Asia, VTR Biotech has developed a global sales network spanning more than 60 countries and regions. By working with research institutions and partners globally, the company has been crucial in transforming animal nutrition, health, and sustainable agriculture using biotechnology.
The establishment of Vnzymes in Frankfurt is a strategic move in VTR Biotech’s international expansion. The European office will concentrate on accelerating innovation in animal nutrition and health, bio-agriculture, and plant extracts, delivering sustainable and efficient biosolutions that benefit both people and the environment.
Dr. Wang Yufeng, the senior technical director of Vnzymes, added that as the global market evolves, true globalization involves more than just entering new markets. It’s about providing relevant innovations that meet local demands while keeping a global perspective. Vnzymes is in a unique position to achieve this in Europe.
Vnzymes’ main products include xylanase and phytase enzymes, which improve nutrient digestibility and phosphorus utilization, and support intestinal health and growth in livestock, along with natural feed additives derived from Macleaya cordata, which increase feed intake, boost immunity, enhance antioxidant capacity, and support sustainable and healthy animal production.
Media contact
Contact Name: Cindy Chen
Company Name: Vnzymes
Website:
Email:
Disclaimer: This content is provided by Vnzymes. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. Globenewswire does not endorse any content on this page.
Legal Disclaimer: This media platform provides the content of this article on an “as-is” basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.
Photos accompanying this announcement are available at:
“`